Top news of the week: 10.03.2020.
#pharma #biospace #lifesciences #Coronavirus #biotech #CoronaOutbreak #COVID19 #teamwork #Biopharma #Academia
Career And Jobs
#Coronavirus Stimulates #Biopharma and #Academia Research Activities and Collaborations
#biospace #lifesciences #biotech #pharma #teamwork
#CoronaOutbreak #CoronaVirus #COVID19
https://t.co/vF6feISKEO
OpenCoronavirus Stimulates Biopharma and Academia Research Activities and Collaborations
Biopharma companies, government regulatory and health agencies and academic centers are stepping forward and working to test or develop vaccines and therapeutics for the disease.
Is Biotech Keeping Up with Diversity and Inclusion Today?
To answer the question of whether biotech is truly keeping up with diversity and inclusion today, the complicated answer is the movement is “ still in progress.”
New hVIVO contract signed with a European Biotech Company
https://t.co/DSshOF7Q6w
#news #pharma #pharmiweb
OpenNew hVIVO contract signed with a European Biotech Company
Initial study for the provision of a RSV human challenge studyRespiratory Syncytial Virus (“RSV”) human challenge study Projected to deliver £3.2m in revenue in 2020 ...
GMGI Trains New Generation of #Biotech Lab Technicians for Bay State’s Booming Industry
#biospace #lifesciences #biotechnology #pharma #pharmaceuticals
https://t.co/57nxni1zDi
OpenGMGI Trains New Generation of Biotech Lab Technicians for Bay State’s Booming Industry
For the past four years, the Gloucester Marine Genomics Institute has been leading the charge training workers for a future in pharmaceutical manufacturing through its Biotechnology Academy.
Akouos nabs meaty $105M raise, adds VC and biotech veterans to board https://t.co/XLgJZvXulH https://t.co/YFXaWbetpt
OpenAkouos nabs meaty $105M raise, adds VC and biotech veterans to board
Boston-based hearing loss gene therapy biotech Akouos has grabbed a $105 million series B funding round.
Ugly list here --
Biopharma stocks take a beating as economic turmoil takes its toll — but some players with coronavirus efforts underway are up
https://t.co/wm3q9D9gOs
OpenBiopharma stocks take a beating as economic turmoil takes its toll — but some players with coronavirus efforts underway are up
The Biogen coronavirus outbreak has left most of its staff working from home — and it’s been no help for its share price. The stock $BIIB is down $5.5% Monday morning, as biopharma in ...
RT @endpts: Ahead of crucial PhII readout, Shionogi lines up an option to buy out biotech partner and its non-amyloid Alzheimer's drug https://t.co/LwNH9lYuxu
OpenAhead of crucial PhII readout, Shionogi lines up an option to buy out biotech partner and its non-amyloid Alzheimer's drug
With the make-or-break results that will prove little Tetra right — or wrong — about its Alzheimer’s drug just around the corner, partner Shionogi is putting itself in a position to act ...
Before joining PsiOxus, Lillie spent four years at Merck, rising to the position of vice president, oncology global medical affairs, and prior to that more than 13 years at Amgen. https://t.co/VJ6WPTjfvE
OpenPsiOxus lures Lillie from Merck to fill CMO position
PsiOxus Therapeutics has hired Tom Lillie away from Merck to work as its chief medical officer. Lillie’s arrival coincides with the initiation of a phase 1 trial of PsiOxus’ quadrivalent ...